MHUAFOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Meihua International Medical Technologies Co., Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026

$6.50+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): 0.4
Dividend yield: –

Meihua International Medical Technologies Co., Ltd. income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	62	97	97	103	104	89	80
Cost of Revenue	43	64	64	65	64	52	47
Gross Profit	19	33	33	38	40	37	32
Research & Development	2.38	3.46	2.75	2.96	2.73	2.49	3.21
General & Administrative	3.21	7.78	6.54	12	4.36	4.58	4.20
Advertising Expenses	0.00	0.00	0.01	0.10	0.02	0.05	0.23
Operating Expenses	11	19	19	27	14	14	13
Operating Income	8.28	14	15	11	26	23	19
Interest Expense	0.24	1.51	0.25	0.19	0.18	0.14	0.10
Interest & Investment Income	1.26	1.01	0.87	0.06	0.02	–	–
Other Non-Operating Income	1.12	-0.69	0.37	0.09	-0.03	-0.27	0.14
Asset Impairment Charges	0	0	0	4.76	–	–	–
Gain (Loss) on Investments	–	–	0.00	0.00	–	–	–
Gain (Loss) on Sale of Assets	–	0.00	-0.10	-0.03	-0.02	0.00	0.01
Pretax Income	9.41	14	15	11	26	24	19
Income Tax Expense	2.62	2.79	3.46	4.71	5.28	4.69	3.82
Net Income incl. Noncontrolling Interests	6.78	11	12	6.18	21	19	15
Minority Interest in Earnings	–	-0.01	-0.03	-0.07	–	–	–
Net Income	6.78	11	12	6.24	21	19	15
EPS (Basic)(per share)	18.04	39.62	48.56	27.00	105.00	95.00	83.00
EPS (Diluted)(per share)	18.04	39.62	48.56	27.00	105.00	95.00	–
Shares Outstanding (Basic, Weighted)(shares)	0.38	0.27	0.24	0.23	0.20	0.20	0.19
Shares Outstanding (Diluted, Weighted)(shares)	0.38	0.27	0.24	0.23	0.20	0.20	0.19
EBITDA	–	–	–	11	27	24	20
Net Interest Income	–	-1.51	-0.25	-0.19	-0.18	0.14	0.10

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 31.0%
Operating margin: 13.4%
Net margin: 11.0%
Return on equity, FY2025: 3.9%

Financial strength

Current ratio: 8.42
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 83.0%

Valuation

P/E ratio: 0.4
Price to sales: –
Price to book: –
Dividend yield: –